T2D patients on combination therapy benefit in switch from sitagliptin to liraglutide
BOSTON – Switching from sitagliptin to liraglutide, in combination with metformin, improved control of hypoglycemia and resulted in greater weight loss in patients with type 2 diabetes, reported Dr....
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news
More News: Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Janumet | Januvia | Metformin | Victoza | Weight Loss